T lymphocyte–specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4 + T cells and impairs antitumor response - Connor J. R. Foster; Jasper Du; Oscar Pundel; Mitchell J. Geer; Ryan C. Ripert; Jia Liu; Taylor A. Heim; Kiyomi Y. Araki; Amanda W. Lund; Jun Wang; Benjamin G. Neel (Proceedings of the National Academy of Sciences, 2025)